For more information, visit pcom.edu or call 229-668-3110
I feel amazing...- Rachel, Semaglutide Patient THE BENEFITS OF GLP-1 Suppresses the Appetite Weight-Loss Quiets Food Noise Reduces Insulin Resistance BEYOND WEIGHT-LOSS: CLINICAL STUDIES The GLP-1 class of medications that semaglutide belongs to has been on the market for over 20 years and is highly studied
Waist circumference decreased by an average of 10.51 cm, indicating preferential reduction of visceral adipose tissue associated with metabolic complications
Setting realistic expectations helps patients stay committed to recovery and avoid returning to high-impact activity too soon.
Pickart L, Thayer L, Thaler MM
The patient must understand that the treatment addresses clinical needs, and is not a shortcut for muscle growth in healthy individuals. The Bottom Line Peptides can play a role in medical treatments for specific conditions, but their use as performance enhancers carries potentially significant risks and ethical concerns